Levi & Korsinsky Alerts Investors of Class Action in APLT
Levi & Korsinsky Alerts APLT Investors about Class Action Lawsuit
Levi & Korsinsky, LLP, a law firm known for its dedication to shareholder rights, has reached out to investors in Applied Therapeutics, Inc. to inform them of a class action securities lawsuit. This lawsuit targets individuals adversely affected by alleged fraudulent activities affecting stock prices.
Understanding the Class Action and Its Implications
The suit aims to recover losses sustained by shareholders during the period when these alleged securities fraud activities occurred. Shareholders who invested in Applied Therapeutics during this time may seek to join the class action to recover losses related to their investments.
What Led to the Lawsuit?
The lawsuit follows a significant event on December 2, which included news that the FDA provided a Complete Response Letter (CRL) regarding Applied Therapeutics' New Drug Application for its primary candidate, govorestat. This communication from the FDA raised concerns among investors as it indicated that approval would not be granted in its current state due to various deficiencies found during the review process.
The Financial Impact on Investors
After the announcement of the CRL, the stock price of Applied Therapeutics saw a dramatic drop. From a closing price of $10.21 before the announcement, shares plummeted to $1.75 within just a few days. This sharp decline sent shockwaves through the investor community, prompting many to reevaluate their positions and seek legal counsel.
Market Response and Legal Action
The reaction of the market highlighted the seriousness of the situation as investors were increasingly concerned about the clinical trial issues referenced in the FDA's warning letter. With a drop in share price of over 80% within a short timeframe, the class action provides a crucial recourse for those impacted.
Next Steps for APLT Investors
Investors who suffered losses during the relevant time frame have a crucial deadline approaching. They may request the Court to appoint them as lead plaintiffs by filing necessary documentation. It’s important to note that participating in the class action entails no costs or obligations, enabling shareholders to recover potential losses.
Levi & Korsinsky's Role
Having established a robust track record over the past two decades, Levi & Korsinsky has successfully secured significant settlements for investors facing similar issues. Their experience and commitment to shareholder rights position them as an ally for investors in navigating complex legal landscapes.
Contact Information for Affected Investors
For those who wish to explore whether they qualify for this class action, Levi & Korsinsky provides various avenues for contact. Investors are encouraged to reach out via telephone or email for assistance with their claims. This proactive step may lead to financial recovery as the class action progresses.
Why Choose Levi & Korsinsky?
The firm boasts a team of experienced professionals dedicated to resolving investor disputes, and their efforts have been recognized through numerous accolades within the realm of securities litigation. As one of the top firms in this field, they are equipped to handle complex cases and share a history of favorable outcomes.
Frequently Asked Questions
What is a class action lawsuit?
A class action lawsuit allows individuals with similar claims against a defendant to band together and file one suit collectively to seek damages.
Who can join the class action against Applied Therapeutics?
Investors who purchased or held shares of Applied Therapeutics during the identified timeframe and suffered financial losses may qualify for the class action.
What steps do I need to take to participate?
Individuals interested in joining the lawsuit should contact Levi & Korsinsky to express their interest and follow the firm's guidance on the necessary documentation.
Are there any costs associated with joining the class action?
No, participating in the class action does not require any costs or financial commitments from class members.
How do I contact Levi & Korsinsky?
You can reach Levi & Korsinsky via telephone at (212) 363-7500 or through their online contact form for further support regarding the lawsuit.
About The Author
Contact Olivia Taylor here.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.